Organism name | Chromolaena odorata |
---|---|
Genus | Chromolaena |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Chromolaena odorata |
---|---|
Linked NCBI taxonomy ID | 103745 |
Linked level | species |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
Species | Activity |
---|---|
Chromolaena odorata (L.) R. M. King & H.Rob. | Analgesic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Analgesic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antiallergic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antiallergic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antibacterial |
Chromolaena odorata (L.) R. M. King & H.Rob. | Anticancer, lung |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antiedemic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antifertility |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antiinflammatory |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antioxidant |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antiradicular |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antiseptic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antiseptic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antispasmodic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Antitussive |
Chromolaena odorata (L.) R. M. King & H.Rob. | Bactericide |
Chromolaena odorata (L.) R. M. King & H.Rob. | Cathartic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Cytotoxic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Decongestant |
Chromolaena odorata (L.) R. M. King & H.Rob. | Digestive |
Chromolaena odorata (L.) R. M. King & H.Rob. | Edemic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Emetic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Emmenagogue |
Chromolaena odorata (L.) R. M. King & H.Rob. | Emmenagogue |
Chromolaena odorata (L.) R. M. King & H.Rob. | Fungicide |
Chromolaena odorata (L.) R. M. King & H.Rob. | Hemostat |
Chromolaena odorata (L.) R. M. King & H.Rob. | Hepatoprotective |
Chromolaena odorata (L.) R. M. King & H.Rob. | Herbicide |
Chromolaena odorata (L.) R. M. King & H.Rob. | Insecticide |
Chromolaena odorata (L.) R. M. King & H.Rob. | Mercury-Binder |
Chromolaena odorata (L.) R. M. King & H.Rob. | Molluscacide |
Chromolaena odorata (L.) R. M. King & H.Rob. | PAF-Inhibitor |
Chromolaena odorata (L.) R. M. King & H.Rob. | Piscicide |
Chromolaena odorata (L.) R. M. King & H.Rob. | Piscicide |
Chromolaena odorata (L.) R. M. King & H.Rob. | Spasmogenic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Stomachic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Stomachic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Tonic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Tonic |
Chromolaena odorata (L.) R. M. King & H.Rob. | Vulnerary |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00004690
![]() |
Laciniatin
/ 3,5,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6-methoxy-4H-1-benzopyran-4-one |
No. 3 | No. 15 |
![]() |
||||
C00004634
![]() |
Rhamnetin
/ 7-Methoxyquercetin / 3,5,3',4'-Tetrahydroxy-7-methoxyflavone / 2-(3,4-Dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4H-1- benzopyran-4-one |
CHEMBL312163
|
C063423
|
20 / 27 / 27 | No. 3 | No. 15 |
![]() |
|
C00004636
![]() |
Tamarixetin
/ 4'-O-Methylquercetin / 3,3',5,7-Tetrahydroxy-4'-methoxyflavone / 3,5,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL226034
|
5 / 6 / 5 | No. 3 | No. 15 |
![]() |
||
C00004643
![]() |
Ombuin
/ 4',7-Dimethylquercetin / 3,5,3'-Trihydroxy-7,4'-dimethoxyflavone / 3,5-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4H-1-benzopyran-4-one |
CHEMBL75589
|
1 / 1 / 1 | No. 3 | No. 15 |
![]() |
||
C00004644
![]() |
Dillenetin
/ 3',4'-Dimethoxyquercetin / 3,5,7-Trihydroxy-3',4'-dimethoxyflavone / 2-(3,4-Dimethoxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one |
CHEMBL2043330
|
No. 3 | No. 15 |
![]() |
|||
C00004649
![]() |
Quercetin 7,3',4'-trimethyl ether
/ 3,5-Dihydroxy-7,3',4'-trimethoxyflavone / 2-(3,4-Dimethoxyphenyl)-3,5-dihydroxy-7-methoxy-4H-1-benzopyran-4-one |
CHEMBL1689343
|
1 / 2 / 0 | No. 3 | No. 15 |
![]() |
||
C00003841
![]() |
Tetramethylscutellarein
/ 5,6,7,4'-Tetramethoxyflavone / Scutellarein 5,6,7,4'-tetramethyl ether / 5,6,7-Trimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL75349
|
C072809
|
9 / 4 / 8 | No. 8 | No. 15 |
![]() |
|
C00004937
![]() |
Marionol
/ 3',4',5,6,7-Pentamethylquercetagetin / Quercetagetin 5,6,7,3',4'-pentamethyl ether / 2-(3,4-Dimethoxyphenyl)-3-hydroxy-5,6,7-trimethoxy-4H-1-benzopyran-4-one |
No. 8 | No. 15 |
![]() |
||||
C00013596
![]() |
Sinensetin
/ Pedalitin permethyl ether / 5,6,7,3',4'-Pentamethoxyflavone / 2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL226507
|
C059295
|
7 / 6 / 7 | 3 / 0 | No. 8 | No. 15 |
![]() |
C00008277
![]() |
4'-Hydroxy-5,6,7-trimethoxyflavanone
|
CHEMBL485055
|
No. 77 | No. 14 |
![]() |
|||
C00006979
![]() |
4,6'-Dihydroxy-2',3',4'-trimethoxychalcone
|
CHEMBL2208192
|
No. 79 |
![]() |
||||
C00006989
![]() |
6'-Hydroxy-3,4,2',3',4'-pentamethoxychalcone
|
CHEMBL458376
|
No. 79 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00003841 C00004634 C00013596 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00003841 C00004634 C00013596 | 2 / 5 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00004634 C00013596 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004636 C00013596 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004649 C00013596 | 2 / 0 |
P04792 | Heat shock protein beta-1 | Unclassified protein | C00004634 C00004636 | 2 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00004634 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00004636 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00013596 | 1 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00004643 | 1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00004634 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003841 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00013596 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00004634 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00003841 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004636 | 4 / 4 |
P04745 | Alpha-amylase 1 | Enzyme | C00004634 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00004634 | 3 / 1 |
P45983 | Mitogen-activated protein kinase 8 | Jnk | C00004634 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00004636 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00004634 | 3 / 3 |
P02545 | Prelamin-A/C | Unclassified protein | C00004634 | 11 / 10 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003841 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00004634 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00003841 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00004634 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00004634 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003841 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00004634 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00004634 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00004634 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00004634 | 1 / 1 |
P45984 | Mitogen-activated protein kinase 9 | Jnk | C00004634 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00003841 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00003841 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00013596
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00013596
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00013596
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#606595 | Charcot-marie-tooth disease, axonal, type 2f; cmt2f |
P04792
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#608634 | Neuronopathy, distal hereditary motor, type iib; hmn2b |
P04792
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#278300 | Xanthinuria, type i |
P47989
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00856 | Distal hereditary motor neuropathies (dHMN) |
P04792
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|